EAM
Eventide Asset Management Portfolio holdings
AUM
$5.71B
This Quarter Return
+11.44%
1 Year Return
+51.18%
3 Year Return
+209.28%
5 Year Return
+283.63%
10 Year Return
+1,480.39%
AUM
$644M
AUM Growth
+$644M
(+98%)
Cap. Flow
+$295M
Cap. Flow
% of AUM
45.8%
Top 10 Holdings %
Top 10 Hldgs %
23.99%
Holding
104
New
10
Increased
74
Reduced
–
Closed
3
Top Buys
| 1 |
Terex
TEX
|
$13.4M |
| 2 |
ROC
ROCKWOOD HLDGS INC
ROC
|
$12.7M |
| 3 |
ININ
Interactive Intelligence Group, inc.
ININ
|
$11.3M |
| 4 |
FPRX
Five Prime Therapeutics, Inc.
FPRX
|
$10.1M |
| 5 |
Agios Pharmaceuticals
AGIO
|
$9.61M |
Top Sells
| 1 |
DWSN
DAWSON GEOPHYSICAL CO
DWSN
|
$2.21M |
| 2 |
Traws Pharma
TRAW
|
$264K |
| 3 |
VVUS
Vivus Inc
VVUS
|
$253K |
Sector Composition
| 1 | Healthcare | 23.69% |
| 2 | Consumer Discretionary | 13.71% |
| 3 | Technology | 11.28% |
| 4 | Industrials | 11% |
| 5 | Materials | 7.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Tesla
TSLA
$1.08T
| $5.48M | 0.85% |
26,300
+12,000
| +84% | +$2.5M |
|
|
AZPN
52
DELISTED
ASPEN TECHNOLOGY INC
AZPN
| $5.44M | 0.85% |
128,500
| – | – |
|
53
Celldex Therapeutics
CLDX
$1.57B
| $5.1M | 0.79% |
288,700
+31,700
| +12% | +$560K |
|
54
Quanta Services
PWR
$55.8B
| $4.95M | 0.77% |
134,000
+54,900
| +69% | +$2.03M |
|
55
Acadia Pharmaceuticals
ACAD
$4.34B
| $4.71M | 0.73% |
193,500
+18,100
| +10% | +$440K |
|
56
Puma Biotechnology
PBYI
$258M
| $4.68M | 0.73% |
44,900
+2,800
| +7% | +$292K |
|
57
J.M. Smucker
SJM
$12B
| $4.51M | 0.7% |
46,400
+10,300
| +29% | +$1M |
|
|
SZYM
58
DELISTED
SOLAZYME INC COM STK (DE)
SZYM
| $4.23M | 0.66% |
364,000
+122,800
| +51% | +$1.43M |
|
59
NOV
NOV
$4.82B
| $3.7M | 0.57% |
47,500
| – | – |
|
|
TTPH
60
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
| $3.28M | 0.51% |
300,900
+204,300
| +211% | +$2.22M |
|
61
AtriCure
ATRC
$1.73B
| $2.71M | 0.42% |
143,800
+74,500
| +108% | +$1.4M |
|
|
ECYT
62
DELISTED
Endocyte, Inc. Common Stock
ECYT
| $2.33M | 0.36% |
98,000
+52,300
| +114% | +$1.25M |
|
63
Prothena Corp
PRTA
$452M
| $2.23M | 0.35% |
+58,300
| New | +$2.23M |
|
|
SLXP
64
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
| $2.12M | 0.33% |
20,500
+11,500
| +128% | +$1.19M |
|
65
Karyopharm Therapeutics
KPTI
$61.4M
| $2.09M | 0.33% |
67,800
+38,200
| +129% | +$1.18M |
|
|
CERN
66
DELISTED
Cerner Corp
CERN
| $2.07M | 0.32% |
+36,800
| New | +$2.07M |
|
|
CBST
67
DELISTED
CUBIST PHARMACEUTICALS INC
CBST
| $2M | 0.31% |
27,400
+15,500
| +130% | +$1.13M |
|
|
CLVS
68
DELISTED
Clovis Oncology, Inc.
CLVS
| $1.96M | 0.3% |
+28,300
| New | +$1.96M |
|
69
Supernus Pharmaceuticals
SUPN
$2.52B
| $1.93M | 0.3% |
+215,500
| New | +$1.93M |
|
70
BioMarin Pharmaceuticals
BMRN
$11.3B
| $1.92M | 0.3% |
28,100
+17,700
| +170% | +$1.21M |
|
|
SAAS
71
DELISTED
inContact, Inc.
SAAS
| $1.86M | 0.29% |
193,300
| – | – |
|
|
HPTX
72
DELISTED
HYPERION THERAPEUTICS INC COM STK (DE)
HPTX
| $1.85M | 0.29% |
71,700
+40,500
| +130% | +$1.04M |
|
|
NTUS
73
DELISTED
Natus Medical Inc
NTUS
| $1.83M | 0.28% |
71,100
+40,300
| +131% | +$1.04M |
|
|
OMED
74
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
| $1.78M | 0.28% |
52,800
+30,300
| +135% | +$1.02M |
|
75
Bruker
BRKR
$4.45B
| $1.68M | 0.26% |
73,900
+43,300
| +142% | +$987K |
|